Bensedin 10mg (Galenika Diazepam) & Valium: Nordiazepam Active Metabolite Accumulation, Muscle Spasm Neurophysiology & Ashton Tapering Schedules

1. Clinical Profile & Manufacturing Heritage: Bensedin 10mg (Galenika Diazepam)

Bensedin is the proprietary brand name for diazepam manufactured by Galenika a.d. (Belgrade, Serbia), one of Europe’s oldest and most respected pharmaceutical manufacturers, founded in 1945. Synthesized in strict compliance with European Pharmacopoeia (Ph. Eur.) and Good Manufacturing Practice (GMP) standards, Bensedin 10mg (Galenika Diazepam) is renowned internationally for its high chemical purity (>99.8% assay) and reliable pharmacokinetic consistency.

Alongside American and British equivalents such as Valium Martin Dow 10mg and Generic Diazepam 10mg USP, Bensedin remains a preferred formulation for clinicians managing acute musculoskeletal spasms, severe panic disorders, and complex benzodiazepine deprescribing regimens.

2. Hepatic Biotransformation: Nordiazepam Accumulation & Steady-State Buffer

The distinctive clinical utility of Bensedin 10mg lies in its unique metabolic fate. Following oral administration, diazepam undergoes rapid gastrointestinal absorption, achieving peak plasma concentration ($T_{max}$) within 30 to 90 minutes. However, parent diazepam ($t_{1/2} approx 20text{–}50text{ hours}$) is only the initial phase of its therapeutic duration.

Through hepatic cytochrome P450 enzymes—predominantly CYP2C19 and CYP3A4—diazepam undergoes oxidative N-demethylation to produce N-desmethyldiazepam (nordiazepam):

• Nordiazepam ($t_{1/2} = 36text{–}200text{ hours}$): Nordiazepam is a potent full agonist at the GABA_A benzodiazepine site. Because of its extremely prolonged terminal half-life, multiple daily doses lead to steady-state accumulation over 1 to 2 weeks. This active metabolite pool acts as a biological “shock absorber,” preventing the steep drop in receptor occupancy that triggers rebound panic.
• Temazepam ($t_{1/2} = 8text{–}22text{ hours}$): Formed via C3-hydroxylation by CYP3A4, exerting pronounced hypnotic and sedative activity.
• Oxazepam ($t_{1/2} = 5text{–}15text{ hours}$): The terminal active metabolite, eliminated through direct Phase II glucuronidation without active renal metabolites.

3. Spinal Neurophysiology: Central Skeletal Muscle Relaxation Mechanisms

Bensedin 10mg is a potent centrally acting muscle relaxant. Unlike peripheral neuromuscular junction blockers (such as succinylcholine or rocuronium), diazepam reduces skeletal muscle tone without interfering with voluntary muscle contraction or respiratory mechanics at standard clinical doses.

Its antispastic mechanism operates via two coordinated central nervous system pathways:

1. Spinal Polysynaptic Reflex Depression: Diazepam binds with high affinity to GABA_A receptor complexes located on internuncial interneurons within the dorsal horn and ventral grey matter of the spinal cord. By potentiating GABAergic chloride conductance, diazepam augments presynaptic inhibition of Ia sensory afferents entering from muscle spindles, diminishing hyperactive stretch reflexes.
2. Supraspinal Reticular Attenuation: Diazepam dampens descending excitatory projections from the lateral reticular formation to spinal alpha and gamma motor neurons, terminating painful localized tonic contractions.

4. The Ashton Protocol: Step-Down Discontinuation & Crossover Guidelines

The Ashton Protocol (developed by Professor C. Heather Ashton at Newcastle University) recommends substituting short-acting benzodiazepines with equivalent doses of long-acting diazepam to achieve successful, permanent deprescribing without precipitating protracted withdrawal syndrome.

Because Bensedin 10mg tablets are precisely scored and easily halved into 5mg increments (or quartered into 2.5mg), they facilitate the fine-grained dose decrements required during late-stage tapering:

5. Forensic Blister Verification: Identifying Authentic Galenika Packaging

Due to widespread counterfeiting of loose tablets in unregulated marketplaces, patients and clinicians must verify the physical authenticity of Bensedin packaging before administration:

• Foil Typography & Backing: Genuine Galenika Bensedin 10mg is distributed in push-through aluminum/PVC blister strips containing 15 tablets each (two strips per standard 30-tablet carton). The backing foil features crisp, deep blue and red branding with the Galenika logo and European product license number.
• Embossed Batch & Expiry: Authentic blister strips have machine-pressed batch numbers and expiry dates stamped into the crimped side border of the foil, impossible to wipe off with solvent.
• Physical Pill Characteristics: Tablets are circular, biconvex, white to off-white, with a clean bisecting score line on one face and smooth reverse. They demonstrate zero chalky crumbling when divided.